Immune Response for Patients With Metastatic Breast Cancer Treated by Everolimus
NCT02854618
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
112
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
OTHER:
additional blood sample
Sponsor
Centre Hospitalier Universitaire de Besancon